Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.9 (
glucose-6-phosphatase
)
3,081
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of
regucalcin
, a calcium-binding protein isolated from rat liver cytosol, on
glucose-6-phosphatase
in the microsomes of rat liver was investigated. Addition of Ca2+ up to 2.5 microM to the enzyme reaction mixture caused a significant increase of
glucose-6-phosphatase
activity in hepatic microsomes, while Ni2+, Zn2+, Cd2+, Cu2+, Mn2+ and Co2+ (20 microM) did not have an appreciable effect. Vanadate (V5+) markedly inhibited the enzyme activity; a significant inhibitory effect was seen at 10 microM V5+. The Ca2+-induced increase of
glucose-6-phosphatase
activity was reversed by the presence of
regucalcin
; the effect was complete at 1.0 microM of the protein. Regucalcium had no effect on the basal activity of the enzyme. Meanwhile, the inhibitory effect of V5+ (10-100 microM) on
glucose-6-phosphatase
was not appreciably blocked by the presence of
regucalcin
(up to 2.0 microM). The present data suggest that hepatic microsomal
glucose-6-phosphatase
is uniquely regulated by Ca2+ and V5+, of various metals, and that the Ca2+ effect is reversed by
regucalcin
. The present study supports the view that
regucalcin
plays an important role as a regulatory protein in liver cell function related to Ca2+.
...
PMID:Effects of Ca2+ and V5+ on glucose-6-phosphatase activity in rat liver microsomes: the Ca2+ effect is reversed by regucalcin. 254 64